Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Wyeth initiates phase IIIb INTORACT study comparing Torisel plus Avastin for RCC

June 5, 2008

Sunesis focuses resources on voreloxin development

June 4, 2008

Calando doses first patient in siRNA phase I clinical trial

June 4, 2008

Phase I study shows safety of E-7820 and cetuximab combination in solid tumor patients

June 4, 2008

Locus enters research collaborations for p38 inhibitors

June 4, 2008

Hana's phase II Marqibo trial meets clinical response criteria

June 4, 2008

Gradalis reports on novel autologous tumor cell vaccine for advanced cancer

June 4, 2008

New treatment options for cancer reported in recent patent literature

June 4, 2008

Adherex presents phase I/II results on ADH-1, a novel N-cadherin-targeting oncolytic

June 4, 2008

TransMolecular initiates phase I unlabeled TM-601 trial in malignant glioma

June 3, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...